Success Story: A Biochemistry Researcher from China Secures I-140 NIW Approval
Client’s Testimonial:
"Thank you very much for the Great news. Thank you very much for all the support you have given me.”
On June 23rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Biochemistry (Approval Notice).
General Field: Biochemistry
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: China
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: June 23rd, 2026
Processing Time: 22 months, 30 days
Case Summary:
The client, who holds a Ph.D. in biochemistry, was conducting research at a U.S. research institution at the time of filing. His work focuses on identifying and elucidating the functions of essential genes and pathways in malaria parasites to support the development of new drugs and therapies. This research is nationally important because it addresses the ongoing risk of malaria transmission in the United States and contributes to global efforts to reduce disease burden.
The client’s proposed endeavor is designed to improve understanding of malaria parasite biology, identify novel drug targets, and inform more effective antimalarial interventions. His research has direct implications for public health preparedness and disease control, supporting U.S. national interests in infectious disease mitigation.
To demonstrate that the client was well-positioned to advance this endeavor, we relied on a focused record of scholarly output and peer recognition. The client’s record included 3 peer-reviewed journal articles (1 first-authored), 2 first-authored conference abstracts, and 13 citations. Rather than presenting these numbers as automatically persuasive, we showed how they reflect a consistent pattern of research productivity, independent reliance on his findings, and recognition by peers in biochemistry and infectious disease research.
We further demonstrated the client’s significance by showing that other researchers have relied on his work. These examples highlighted how his research is applied in the development of malaria therapeutics and functional studies in related infectious diseases, confirming that his contributions extend beyond publication metrics to practical scientific impact.
The client’s expertise and technical accomplishments have been widely recognized within the research community. His innovative approaches to malaria parasite genetics, and drug-target identification have been cited by other scientists and incorporated into subsequent studies, demonstrating that his work is valued and relied upon by peers in the field. This recognition reinforces his ability to continue advancing critical research that supports public health and therapeutic development in the United States.
The client’s I-140 NIW petition was approved in just nearly 23 months without receiving any RFE. This approval reflects the successful presentation of a case grounded in biochemistry expertise, applied parasite biology research, independent scholarly reliance, peer recognition, and the national importance of advancing malaria therapeutics that may protect public health in the United States.